Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lannett to supply digoxin tablets in US
The company has secured additional active pharmaceutical ingredient for its digoxin tablets, 0.125mg and 0.25mg. Digoxin is indicated for the treatment of mild to moderate heart failure as
The company has secured additional active pharmaceutical ingredient for its digoxin tablets, 0.125mg and 0.25mg. Digoxin is indicated for the treatment of mild to moderate heart failure as
Tim Martinson, president of Virtual Imaging, will continue to manage the day-to-day operations of the organization, and report directly to Joe Adachi, president and CEO of Canon USA.
The lawsuit was filed in response to an abbreviated new drug application (ANDA) filed by Natco seeking FDA approval to market and sell generic versions of Shire’s 500mg,
According to Covaris, the DNA shearing service is a nice alternative sample prep tool for next-generation sequencing customers. In addition, Covaris is introducing eCommerce capability on its website.
Depomed’s Phase III registration program for Serada in menopausal hot flashes includes two randomized, double-blind, placebo-controlled studies of approximately 540 patients per study. The treatment duration of the
Under the terms of the agreement, Nitten is responsible for securing regulatory approval and has exclusive rights to commercialize AzaSite for ocular bacterial infection in Japan and Taiwan.
DiaMedica, a drug discovery and development company, has reported top-line results of a proof-of-concept Phase IIa trial for DM-99, the company’s third drug in clinical development for type
HemaQuest Pharmaceuticals, a biopharmaceutical company, has received two orphan medicinal product designations from the European Commission for its product HQK-1001 for the treatment of sickle cell disease and
Acacia Pharma, a UK-based pharmaceutical company, has initiated a Phase IIa study of its product APD209 to treat cachexia in cancer patients. According to Acacia, APD209 has been
Alliance HealthCard, a provider of health discount and lifestyle benefits, has completed its acquisition of Access Plans USA. Access Plans markets health insurance and develops and distributes consumer-driven